PE20150354A1 - Metodos para preparar triazolopiridinas sustituidas - Google Patents

Metodos para preparar triazolopiridinas sustituidas

Info

Publication number
PE20150354A1
PE20150354A1 PE2015000017A PE2015000017A PE20150354A1 PE 20150354 A1 PE20150354 A1 PE 20150354A1 PE 2015000017 A PE2015000017 A PE 2015000017A PE 2015000017 A PE2015000017 A PE 2015000017A PE 20150354 A1 PE20150354 A1 PE 20150354A1
Authority
PE
Peru
Prior art keywords
phenyl
triazolopyridines
methods
compounds
propanamide
Prior art date
Application number
PE2015000017A
Other languages
English (en)
Spanish (es)
Inventor
Volker Schulze
Franz-Josef Mais
Original Assignee
Bayer Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Pharma AG filed Critical Bayer Pharma AG
Publication of PE20150354A1 publication Critical patent/PE20150354A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PE2015000017A 2012-07-10 2013-07-03 Metodos para preparar triazolopiridinas sustituidas PE20150354A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12175640 2012-07-10
EP12185590 2012-09-24
EP13170585 2013-06-05

Publications (1)

Publication Number Publication Date
PE20150354A1 true PE20150354A1 (es) 2015-03-21

Family

ID=48793197

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2015000017A PE20150354A1 (es) 2012-07-10 2013-07-03 Metodos para preparar triazolopiridinas sustituidas

Country Status (24)

Country Link
US (1) US9388177B2 (https=)
EP (1) EP2872506A1 (https=)
JP (1) JP6238979B2 (https=)
KR (1) KR20150040845A (https=)
CN (1) CN104603136B (https=)
AP (1) AP3778A (https=)
AU (1) AU2013289381A1 (https=)
BR (1) BR112015000308A2 (https=)
CA (1) CA2878481A1 (https=)
CL (1) CL2015000038A1 (https=)
CO (1) CO7160002A2 (https=)
CR (1) CR20150006A (https=)
DO (1) DOP2015000007A (https=)
EA (1) EA027544B1 (https=)
HK (1) HK1206731A1 (https=)
IL (1) IL236265A (https=)
IN (1) IN2015DN00085A (https=)
MX (1) MX2015000348A (https=)
NZ (1) NZ703020A (https=)
PE (1) PE20150354A1 (https=)
PH (1) PH12015500061A1 (https=)
SG (1) SG11201408419QA (https=)
TN (1) TN2015000008A1 (https=)
WO (1) WO2014009219A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HK1222849A1 (zh) * 2013-06-07 2017-07-14 Bayer Pharma Aktiengesellschaft 具有作爲mps-1抑制剂的活性的取代的三唑并吡啶类
TN2015000543A1 (en) 2013-06-11 2017-04-06 Bayer Pharma AG Combinations for the treatment of cancer comprising a mps-1 kinase inhibitor and a mitotic inhibitor
AP2015008898A0 (en) * 2013-06-11 2015-12-31 Bayer Pharma AG Prodrug derivatives of substituted triazolopyridines
ES2966392T3 (es) 2015-04-17 2024-04-22 Crossfire Oncology Holding B V Biomarcadores pronósticos para quimioterapia inhibidora de TTK
TW201800408A (zh) 2016-06-15 2018-01-01 拜耳製藥公司 Mps-1抑制劑

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003030937A1 (en) * 2001-10-05 2003-04-17 Ono Pharmaceutical Co., Ltd. Remedies for stress diseases comprising mitochondrial benzodiazepine receptor antagonists
WO2005110410A2 (en) * 2004-05-14 2005-11-24 Abbott Laboratories Kinase inhibitors as therapeutic agents
UA89503C2 (uk) * 2004-09-13 2010-02-10 Х. Луннбек А/С Заміщені похідні аніліну
EP1799680A2 (en) * 2004-10-07 2007-06-27 Warner-Lambert Company LLC Triazolopyridine derivatives as antibacterial agents
US20060194823A1 (en) * 2004-12-22 2006-08-31 Georg Kettschau Sulfonamido-macrocycles as Tie2 inhibitors and the salts thereof, a pharmaceutical composition comprising these compounds, the method of preparing and the use thereof
EP2029605A1 (en) * 2006-06-06 2009-03-04 Schering Corporation Imidazopyrazines as protein kinase inhibitors
EP1870416A1 (en) * 2006-06-21 2007-12-26 Bayer Schering Pharma Aktiengesellschaft Sulphonamido-macrocycles as tie2 inhibitors
BRPI0716239A2 (pt) 2006-08-30 2013-08-13 Cellzome Ltd derivados de triazol como inibidores de cinase
JO3598B1 (ar) * 2006-10-10 2020-07-05 Infinity Discovery Inc الاحماض والاسترات البورونية كمثبطات اميد هيدروليز الحامض الدهني
CA2693232A1 (en) 2007-07-18 2009-01-22 Novartis Ag Bicyclic heteroaryl compounds and their use as kinase inhibitors
MX2010002115A (es) 2007-08-23 2010-06-01 Aztrazeneca Ab 2-anilinopurin-8-onas como inhibidores de ttk/mps1 para el tratamiento de trastornos .proliferativos.
CA2691448A1 (en) 2007-08-31 2009-03-05 Dominique Swinnen Triazolopyridine compounds and their use as ask inhibitors
GB0719803D0 (en) 2007-10-10 2007-11-21 Cancer Rec Tech Ltd Therapeutic compounds and their use
GB0724342D0 (en) * 2007-12-13 2008-01-30 Prolysis Ltd Anitbacterial compositions
WO2009137322A2 (en) * 2008-05-05 2009-11-12 The Trustees Of The University Of Pennsylvania Processes for the preparation of biphenyl compounds
US20110212053A1 (en) * 2008-06-19 2011-09-01 Dapeng Qian Phosphatidylinositol 3 kinase inhibitors
SG173610A1 (en) 2009-02-13 2011-09-29 Fovea Pharmaceuticals Sa [1, 2, 4] triazolo [1, 5 -a] pyridines as kinase inhibitors
JP6168773B2 (ja) 2009-04-29 2017-07-26 バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングBayer Intellectual Property GmbH 置換イミダゾキノキサリン
EP2438066A2 (en) * 2009-06-05 2012-04-11 Cephalon, Inc. PREPARATION AND USES OF 1,2,4-TRIAZOLO [1,5a]PYRIDINE DERIVATIVES
WO2010141360A1 (en) * 2009-06-05 2010-12-09 Merck Sharp & Dohme Corp. Biaryl benzotriazole derivatives
JP5728683B2 (ja) 2009-09-04 2015-06-03 バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングBayer Intellectual Property GmbH チロシンスレオニンキナーゼ阻害剤としての置換アミノキノキサリン
EP2343294A1 (en) * 2009-11-30 2011-07-13 Bayer Schering Pharma AG Substituted triazolopyridines
EP2343295A1 (en) * 2009-11-30 2011-07-13 Bayer Schering Pharma AG Triazolopyridine derivates
EP2343297A1 (en) * 2009-11-30 2011-07-13 Bayer Schering Pharma AG Triazolopyridines
UY33452A (es) * 2010-06-16 2012-01-31 Bayer Schering Pharma Ag Triazolopiridinas sustituidas
WO2012044567A2 (en) * 2010-09-30 2012-04-05 Merck Sharp & Dohme Corp. Imidazole derivatives
RS54044B1 (sr) 2011-04-21 2015-10-30 Bayer Intellectual Property Gmbh Triazolopiridini
WO2012160029A1 (en) * 2011-05-23 2012-11-29 Bayer Intellectual Property Gmbh Substituted triazolopyridines
UA112096C2 (uk) * 2011-12-12 2016-07-25 Байєр Інтеллектуал Проперті Гмбх Заміщені триазолопіридини та їх застосування як інгібіторів ttk

Also Published As

Publication number Publication date
IN2015DN00085A (https=) 2015-05-29
US20150148542A1 (en) 2015-05-28
HK1206731A1 (en) 2016-01-15
JP6238979B2 (ja) 2017-11-29
SG11201408419QA (en) 2015-01-29
AU2013289381A1 (en) 2015-01-22
TN2015000008A1 (en) 2016-06-29
IL236265A0 (en) 2015-02-26
DOP2015000007A (es) 2015-02-15
BR112015000308A2 (pt) 2017-06-27
EA201590116A1 (ru) 2015-07-30
AP2014008177A0 (en) 2014-12-31
US9388177B2 (en) 2016-07-12
EP2872506A1 (en) 2015-05-20
JP2015523372A (ja) 2015-08-13
CN104603136A (zh) 2015-05-06
IL236265A (en) 2017-07-31
CA2878481A1 (en) 2014-01-16
MX2015000348A (es) 2015-04-14
CO7160002A2 (es) 2015-01-15
CR20150006A (es) 2015-02-16
EA027544B1 (ru) 2017-08-31
CL2015000038A1 (es) 2015-03-13
CN104603136B (zh) 2017-06-27
KR20150040845A (ko) 2015-04-15
AP3778A (en) 2016-08-31
WO2014009219A1 (en) 2014-01-16
PH12015500061A1 (en) 2015-03-02
NZ703020A (en) 2017-08-25

Similar Documents

Publication Publication Date Title
EA201390199A1 (ru) 2-замещенные-8-алкил-7-оксо-7,8-дигидропиридо[2,3-d]пиримидин-6-карбонитрилы и их применение
CL2014000746A1 (es) Compuestos derivados de 3-pirimidin-4-il-oxazolidin-2-ona y sus sales, como inhibidores de las proteinas idh mutantes; composicion farmaceutica que los comprende, utiles para el tratamiento de trastornos de la proliferacion celular tal como el cancer.
UY33985A (es) Sales de 2,3-dihidroimidazo [1,2-c] quinazolina sustituida
UY32863A (es) COMPUESTOS DE HEXAHIDROOXAZINOPTERINA PARA USO COMO INHIBIDORES DE mTOR
AR094204A1 (es) Composiciones para el cuidado oral que contienen haluros de acido amino
UY34104A (es) ?compuestos derivados benzamídicos heterocíclicos, procesos e intermedios para su preparación, composiciones y métodos para su uso?.
UY33337A (es) DERIVADOS SUSTITUIDOS DE 1H-PIRAZOL[ 3,4-d]PIRIMIDINA COMO INHIBIDORES DE LAS FOSFOINOSITIDA 3-QUINASAS
CR20130550A (es) Ciclopropilaminas como inhibidores de desmetilasa 1 específica de lisina
UY34301A (es) COMPUESTOS Y COMPOSICIONES COMO INHIBIDORES DE LA QUINASA c-Kit
CR20130349A (es) COMPUESTOS SUSTITUIDOS DE N-(1H- INDAZOL-4-IL) IMIDAZO [1,2-a] PIRIDIN-3-CARBOXAMIDA COMO INHIBIDORES DE LA TIROSINA QUINASA RECEPTORA DE TIPO III
CU24272B1 (es) Derivados de tetrahidropirido-pirimidina como inhibidores de mek
CR20140034A (es) Métodos para tratar el cáncer por el uso de antagonistas de unión al eje pd-1e inhibidores de mek
UY33943A (es) Derivados espirocíclicos de isoxazolina como agentes antiparasitarios.
UY34300A (es) COMPUESTOS Y COMPOSICIONES COMO INHIBIDORES DE LA QUINASA c-Kit
UY4149Q (es) Golosina para mascota
UY35241A (es) Compuestos antivirales
CO6531496A2 (es) Amidas sustituidas con halógenoalquilo como insecticidas y acaricidas
CU24045B1 (es) Aril piridinas como inhibidoras de sintasa de aldosterona
CR20130063A (es) Métodos para la preparación de profármacos de fosforamidato diastereoméricamente puros
CR20140204A (es) Métodos para preparar análogos nucleotídicos antivirales
PE20151501A1 (es) Inhibidores de prmt5 y sus usos
CR20140133A (es) Compuestos de piridazinona y sus usos como inhibidores de daao
MX2015012414A (es) Sal de omecamtiv mecarbilo y proceso para preparar la sal.
CO6801757A2 (es) Derivados de pirazolo pirocetona para usarse como inhibidores de la acetil coa carboxilasa
PE20150354A1 (es) Metodos para preparar triazolopiridinas sustituidas

Legal Events

Date Code Title Description
FD Application declared void or lapsed